Kentuckians who have finished treatment for organ cancers and melanoma, among others, no longer need to wait more than a year ...
With a $1 million grant, University of Auckland scientists hope to change the lives of hundreds of Kiwis who lose their lives ...
Investigators evaluated the efficacy and safety of toripalimab versus dacarbazine as the first-line treatment in advanced melanoma predominantly of acral subtype.
Reversing the standard approved dose levels of nivolumab (Opdivo) and ipilimumab (Yervoy) in metastatic melanoma led to less ...
A major achievement with far-reaching implications for treating deadly skin cancer has been discovered by Tel Aviv University ...
The anti-tumor immune response involves a series of complex steps mediated by various immune cells and signaling molecules.
Even with breakthroughs, treatment for advanced squamous cell carcinoma is more complex. Patients often need more than one treatment. Many patients with this advanced cancer are cared for by a team of ...
US Oncologists anticipate rapid biosimilar uptake - up to 50% of PD-1/PD-L1 eligible patients within the first year - while ...
Researchers found better detection, treatment and decreased smoking have been immensely helpful in reducing deaths due to ...
On Monday, Kentucky Blood Center Medical Director Dr. Dennis Williams eliminated restrictions for certain cancers including ...
What is the outlook for someone who has squamous cell carcinoma of the skin? The outlook is excellent when found early and properly treated. More than 90% of patients are cured. FDA-approved ...
Kentucky Blood Center has updated its donor eligibility rules, allowing many cancer survivors to donate blood one year after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback